StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 1.3
Power Rank trend -> Rising
07/26/2024 16:10:00 EST
Elanco Animal Health (ELAN)
Industry: Drug Manufacturers - Specialty & Generic
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, ELAN has been trading in a range between $14.43 and $12.72 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
The AI powered stock chart is in a Red zone currently. We would avoid this stock.
Upside / Downside Potential
Elanco Animal Health $ELAN entered a Red zone 21 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $13.81, a potential upside of 7.05% from the recent price of 12.90. The stock is trading 45.74% (potential upside) below its 52 week high of $18.80 and 51.41 % (potential downside) above its 52 week low of $8.52 - based on the recent price.
Company Summary
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations.
News
| FIVE STOCK ALERT: Five Below, Inc. Investors are Notified that the Company is being Investigated for Securities Fraud – Contact BFA Law if you Lost Money on Your Investment NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Source: Accesswire Fri, 26 Jul 2024 15:33:00 -0400 Sentiment: Neutral |
| ELAN STOCK ALERT: Elanco Investors are Notified that the Company is being Investigated for Securities Fraud – Contact BFA Law if you Lost Money on Your Investment NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Source: Accesswire Fri, 26 Jul 2024 15:33:00 -0400 Sentiment: Neutral |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. Source: GlobeNewsWire Fri, 26 Jul 2024 10:37:00 -0400 Sentiment: Neutral |
| Elanco Animal Health (ELAN) Faces Scrutiny Over Delayed Product Launches – Hagens Berman SAN FRANCISCO, July 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Elanco Animal Health Incorporated (NYSE: ELAN) investors who suffered substantial losses to submit your losses now. Source: GlobeNewsWire Thu, 25 Jul 2024 13:18:00 -0400 Sentiment: Neutral |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN NEW YORK , July 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. Source: PRNewsWire Wed, 24 Jul 2024 20:00:00 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 18.8 52 Week Low: 8.52 Beta: 1.424 50 Day MA: 15.93 200 Day MA: 14.3404 Earnings / Revenue Trends Qtr Earnings Growth YOY: -0.714 Qtr Revenue Growth YOY: -0.041 Forward PE: 15.1057 Trailing PE: 0